Investing News

Idera Pharmaceuticals Enters into a Clinical Development Support Agreement with Pillar Partners Foundation to Expand the Clinical Research on IMO-2125

Markets
TSX	21125.90	-487.28
TSXV	944.05	-31.53
DOW	34899.34	-905.04
S&P 500	4594.62	-106.84
NASD	15491.66	-353.57
ASX	7279.30	-128.00

Markets

TSX

21125.90

-487.28

TSXV

944.05

-31.53

DOW

34899.34

-905.04

S&P 500

4594.62

-106.84

NASD

15491.66

-353.57

ASX

7279.30

-128.00

Commodities
Gold	1792.60	+0.99
Silver	23.13	+0.02
Copper	4.29	-0.18
Palladium	1751.49	+10.50
Platinum	955.50	+2.50
Oil	68.17	-10.22
Heating Oil	2.09	-0.29
Natural Gas	5.49	+0.43

Commodities

Gold

1792.60

+0.99

Silver

23.13

+0.02

Copper

4.29

-0.18

Palladium

1751.49

+10.50

Platinum

955.50

+2.50

Oil

68.17

-10.22

Heating Oil

2.09

-0.29

Natural Gas

5.49

+0.43

Investing News NetworkYour trusted source for investing success

solid tumors

Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI-006

Idera Pharmaceuticals Enters into a Clinical Development Support Agreement with Pillar Partners Foundation to Expand the Clinical Research on IMO-2125

Epizyme Announces Publication of Tazemetostat Phase 1 Clinical Data in The Lancet Oncology

Bio-Path Holdings Reports Full Year 2017 Financial Results

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

Cellectar Granted Seminal U.S. Patent for Phospholipid-Ether Analogs as Cancer-Targeting Drug Vehicles

Cotinga Pharmaceuticals Provides Update on COTI-2 Clinical Programs

Epizyme Reports Fourth Quarter and Full Year 2017 Operating Results and 2018 Milestones

Aduro Announces Milestone Achieved under Merck Collaboration for Initiation of Anti-CD27 Phase I Trial in Advanced Solid Tumors

Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results

Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine

Advanced Proteome Therapeutics Enters Collaboration to Develop Cancer Therapeutic

Cellectar Biosciences Obtains Additional Patents

Atara Will Join Forces with Merck for Clinical Trial

MARKETS

COMMODITIES

DOWNLOAD FREE REPORTS

Top Stories This Week: Powell Gets Fed Nomination, Using Gold in a Market Correction

Cannabis Weekly Round-Up: Germany Moves Ahead on Path to Adult Use

Lower ETF Interest Weighing on Gold After Banner Year

Why Scandium Could be a Huge Opportunity

Carbon Capture and Storage: Basic Facts for Investors

BROWSE TOPICS

Featured stocks

HydroGraph Clean Power

Lords & Company Worldwide Holdings

Gwella Mushrooms

Jazz Resources

CoinSmart Inc

Nano One Materials